Utility of 99mTc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging
Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.
Source: Cancer Biotherapy and Radiopharmaceuticals - Category: Cancer & Oncology Authors: Ghazal Norouzi Sara Nikdel Elahe Pirayesh Yazdan Salimi Mahasti Amoui Hamidreza Haghighatkhah Mohammad Ali Ghodsi Rad Elmira Javanijouni Sepideh Khoshbakht Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Fatty Liver Disease (FLD) | Heart | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Perfusion | Urology & Nephrology